Reply to Early Onset Effluvium Secondary to COVID-19 and Body-Hair Effluvium

    December 2021 in “ Journal of The American Academy of Dermatology ”
    Carlos Gustavo Wambier, Antonella Tosti
    Image of study
    TLDR COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.
    The document discusses the different types of hair loss that can occur after a COVID-19 infection, including dystrophic anagen effluvium and alopecia areata. The authors note that the duration of hair shedding can range from 12 to 100 days and may be associated with the hair cycle phase and presence or absence of chronic inflammation. They also highlight the potential for misdiagnosis, as diffuse alopecia areata can be difficult to distinguish from chronic telogen effluvium. The document also mentions the use of Janus Kinase inhibitors for treating alopecia areata, with some of these drugs showing benefits for COVID-19 patients. However, it remains unknown if anti-inflammatory therapies can affect post-COVID-19 hair loss. The authors also note a rare characteristic of effluvium observed in their patients: body hair effluvium. They encourage further studies on this phenomenon. Finally, they state that up to 20% of COVID-19 patients have cutaneous manifestations, and dermatologists should be aware of the different types of hair loss that can occur post-infection.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 15 results

      community Hairloss is mentally exhausting

      in Chat  25 upvotes 4 years ago
      The conversation is about the mental toll of hair loss and seeking alternatives to finasteride. Suggestions include using minoxidil, considering pumpkin seed oil, and possibly seeking counseling for body dysmorphic disorder.

      community 5MG finasteride everyday June 1st 2024 - October 7th 2024

      in Progress Pictures  182 upvotes 2 months ago
      The user has been using 1.25 mg of finasteride daily since June 2024 to promote hair regrowth and thickness, considering switching to dutasteride if results are unsatisfactory. They are hesitant to add minoxidil due to cost and potential side effects but have seen some progress with finasteride alone.

      community 5.5 months on oral min questions. Please help😭

      in Treatment  11 upvotes 3 months ago
      The user has been on finasteride for over a year and switched from topical to oral minoxidil five months ago, but is unsure if the current shedding and small hairs are signs of improvement or worsening. They are seeking advice on whether to wait longer or switch treatments.

    Similar Research

    5 / 1000+ results
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research 2015

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.
      Alopecia Areata: Comprehensive Overview and Management

      research Alopecia Areata: Comprehensive Overview and Management

      1 citations, May 2017 in “InTech eBooks”
      The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.
      Hair Disorders

      research Hair Disorders

      January 2019 in “Elsevier eBooks”
      Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.